Abstract
N-[[[(2,4-diaminopteridin-6-yl)methyl]amino]benzyl]-L-glutamic acid (deoxaminopterin, 1), a new aminopterin analog containing a CH2 group in the side chain in place of the amide C.dbd.O, was synthesized by condensation of 2,4-diamino-6-(bromomethyl)pteridine with diethyl N-(p-aminobenzyl)-L-glutamate, followed by saponification with a stoichiometric amount of barium hydroxide in 50% ethanol. The apparent importance of the amide C.dbd.O group as a structural determinant of biological activity was indicated by the finding that 1 has 10- to 20-fold lower affinity for bacterial dihydrofolate reductase than aminopterin, is not toxic to L1210 murine leukemia cells in culture at a concentration of up to 1.0 .mu.M and shows no antitumor effect in L1210 leukemic mice at doses as high as 240 mg/kg.

This publication has 12 references indexed in Scilit: